The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

A new wave of scientific understanding is placing ferroptosis, a distinct form of iron-dependent cell death, at the forefront ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...

There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk.

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

Treating breast cancer remains a major medical challenge worldwide. This is largely due to the ability of breast cancer cells ...

Scientists have uncovered a surprising new way the immune system fights cancer, overturning a core belief that has guided ...

Growing momentum for RAS inhibition at ASCO highlights Namodenoson’s RAS pathway inhibition and encouraging data in ...

A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously unrecognized roles in retina and brain blood vessels. The findings were ...

For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are ...